BiotechTube
Home/GenexGen/Dror Assa
DA

Dror Assa

CSO

GenexGen

Therapeutic Areas

ImmunologyRare DiseaseInflammation

GenexGen Pipeline

DrugIndicationPhase
MYD88 Epigenetic RepressorHemophagocytic lymphohistiocytosis (HLH)Pre-clinical

Leadership Team at GenexGen

AK
Amir Kiani
Co-founder and CEO
JH
Jin Huh
CTO
GC
George Church
Scientific Co-founder and Advisor
ME
Mo Ebrahimkhani
Co-founder and Scientific Advisor
SK
Samira Kiani
Co-founder and Scientific Advisor
View full GenexGen profile